Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Canada to Develop New Isotope Production Methods

By BiotechDaily International staff writers
Posted on 11 Mar 2013
An aging reactor and a worldwide looming shortage of medical isotopes has driven Canada to search for alternatives methods to manufacture technetium-99m (99mTc).

At the moment, Canada's only source of the isotope is the National Research Universal (NRU; Chalk River, Ontario, Canada) reactor at Chalk River Laboratories (CRL, Ontario, Canada), which produces about a third of the world's supply. But the reactor has been plagued with safety and operational problems, leading to worldwide shortages, and its license is set to expire in 2016. Consequently, Canada is investing close to USD 21 million in three projects in western Canada that have demonstrated the ability to produce the key medical isotope without a nuclear reactor.

Two of the research institutes, the national laboratory for particle and nuclear physics (TRIUMF; Vancouver, BC, Canada) and the University of Alberta (Edmonton, Canada) are using cyclotron technology to produce the isotope, while the third, Prairie Isotope Production Enterprise (PIPE; Pinawa, MB, Canada), is using a linear accelerator.

In the cyclotron process, the machine bombards a target of molybdenum-100 with high-energy protons, converting some of its atoms to molybdenum-99 (Mo-99). Then chemical processing removes technetium-99 from the target, ready for use. The PIPE technology uses an electron accelerator rather than a nuclear reactor to make the Mo-99. The electron accelerator sprays electricity onto molybdenum metal, which produces the Mo-99 radioisotope. Next, a chemical process is used to fabricate the Tc-99m.

“The Harper Government is investing in Canadian expertise to help ensure new sources of supply for medical isotopes used in diagnosing various diseases, such as cancer and heart disease,” said Joe Oliver Canada’s natural resources minister. “We are investing in the work needed to attract private sector interest and to bring new technologies to market, and to help ensure that isotope production is on a sound commercial footing.”

Tc-99m is obtained from the decay of its parent isotope Mo-99 compounds that are packed into nuclear "generators" and distributed to hospitals, where nuclear medicine specialists can draw off the Tc-99m as needed for about a week. Tc-99m is used in 80% of nuclear medicine diagnostic procedures in Canada, and about 85% of all medical imaging procedures worldwide. It is currently made in reactors in Canada, the Netherlands, Belgium, France, Australia, and South Africa.

Related Links:

National Research Universal
TRIUMF
Prairie Isotope Production Enterprise



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This micrograph depicts the presence of aerobic Gram-negative Neisseria meningitidis diplococcal bacteria; magnification 1150x (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Infection by Meningitis Bacteria Depends on Dimerization State of Certain Host Cell Proteins

A team of molecular microbiologists has untangled the complex three-way interaction between the non-integrin laminin receptor (LAMR1), galectin-3 (Gal-2), and the pathogenic bacterium Neisseria meningitidis.... Read more

Drug Discovery

view channel

Molecule in Green Tea Used as Carrier for Anticancer Proteins

A molecule that is a key ingredient in green tea can be employed as a carrier for anticancer proteins, forming a stable and effective therapeutic nanocomplex. This new discovery could help to construct better drug-delivery systems. Some cancer treatments depend on medication comprising the therapeutic drug and a carrier... Read more

Lab Technologies

view channel
Image: The UC Santa Cruz Ebola Genome Portal contains links to the newly created Ebola browser and to scientific literature on the deadly virus (Photo courtesy of UCSC).

Ebola Genome Browser Now Online to Help Scientists’ Respond to Crisis

A US genomics institute has just released a new Ebola genome browser to help international researchers develop a vaccine and antiserum to help stop the spread of the Ebolavirus. The investigators led... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.